Sign in
4

Changes in Ownership

ARS Pharmaceuticals, Inc. Filed Acc 0000947871-23-000915

Director bought 500,000 shares at $6.20 ($3,100,000)

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-08-29 Purchase : show line 1 in the form +500,000 $6.20 $3,100,000 8,019,187 I
Open-market purchases · 500,000 sh · avg $6.20 · $3,100,000
Loading xslF345X05/ownership.xml…